Q1 EPS Estimates for ProAssurance Raised by Zacks Research

ProAssurance Co. (NYSE:PRA) – Investment analysts at Zacks Research upped their Q1 2025 earnings estimates for ProAssurance in a research report issued to clients and investors on Thursday, December 5th. Zacks Research analyst K. Dey now forecasts that the insurance provider will earn $0.18 per share for the quarter, up from their previous forecast of $0.17. The consensus estimate for ProAssurance’s current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance’s Q2 2025 earnings at $0.20 EPS, Q3 2025 earnings at $0.23 EPS, FY2025 earnings at $0.84 EPS, Q1 2026 earnings at $0.21 EPS, Q2 2026 earnings at $0.22 EPS, Q3 2026 earnings at $0.24 EPS and FY2026 earnings at $0.94 EPS.

Other equities research analysts also recently issued research reports about the company. Piper Sandler downgraded ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 price objective for the company. in a report on Monday, November 11th. StockNews.com lowered shares of ProAssurance from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Finally, Truist Financial upped their price objective on shares of ProAssurance from $14.00 to $18.00 and gave the stock a “hold” rating in a report on Tuesday, November 12th.

ProAssurance Stock Performance

Shares of ProAssurance stock opened at $16.84 on Monday. The business has a 50-day simple moving average of $15.85 and a 200 day simple moving average of $13.95. ProAssurance has a one year low of $10.76 and a one year high of $17.79. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.28 and a quick ratio of 0.28. The firm has a market capitalization of $861.53 million, a price-to-earnings ratio of 20.29 and a beta of 0.27.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of PRA. Zacks Investment Management purchased a new stake in ProAssurance in the 3rd quarter valued at $5,140,000. Assenagon Asset Management S.A. grew its stake in shares of ProAssurance by 91.4% in the 3rd quarter. Assenagon Asset Management S.A. now owns 485,501 shares of the insurance provider’s stock worth $7,302,000 after acquiring an additional 231,852 shares in the last quarter. Cubist Systematic Strategies LLC raised its holdings in shares of ProAssurance by 567.5% in the second quarter. Cubist Systematic Strategies LLC now owns 151,434 shares of the insurance provider’s stock valued at $1,851,000 after purchasing an additional 128,747 shares during the last quarter. Dana Investment Advisors Inc. lifted its position in shares of ProAssurance by 33.6% during the second quarter. Dana Investment Advisors Inc. now owns 434,850 shares of the insurance provider’s stock valued at $5,314,000 after purchasing an additional 109,253 shares in the last quarter. Finally, Wellington Management Group LLP boosted its holdings in ProAssurance by 3.0% during the third quarter. Wellington Management Group LLP now owns 3,164,085 shares of the insurance provider’s stock worth $47,588,000 after purchasing an additional 91,987 shares during the last quarter. Institutional investors own 85.58% of the company’s stock.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.